News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

NicOx SA (COX.PA)'s Ordinary Shareholder Meeting on June 6, 2012

5/18/2012 9:21:44 AM

SOPHIA ANTIPOLIS CEDEX, FRANCE--(Marketwire - May 18, 2012) -


NicOx's Ordinary Shareholder Meeting

May 18, 2012. Sophia Antipolis, France.

NicOx S.A. (EURONEXT: COX) (PARIS: COX) has convened an ordinary shareholder meeting on second call on the same agenda on Wednesday June 6, 2012 at 2:00 pm CET at the Palais de la Méditerranée - 13 promenade des Anglais - 06000 Nice - France.

The documents mentioned in articles L.225-115, R. 225-81 and R. 225-83 of the French Code de commerce, including a proxy voting form, are sent to shareholders upon written request. These documents will also be made available to shareholders at the headquarters and on the website of the Company (

NicOx (Bloomberg: COX:FP, Reuters: NCOX.PA) is building an international late-stage development and commercial Ophthalmology Company based around therapeutics, diagnostics and devices. As of March 2012, NicOx holds an 11.8% stake in the UK-based ophthalmology company Altacor, with an option to acquire the remaining shares, as the first step of a transformation into a late-stage development and commercial ophthalmic Company.

NicOx is also developing an internal portfolio of New Molecular Entities (NMEs) through the application of its proprietary nitric oxide-donating R&D platform. The Company's pipeline includes several nitric oxide-donating NMEs for the potential treatment of ophthalmological, inflammatory and cardio-metabolic diseases, which are in development internally and with partners, who include Bausch + Lomb, Merck (known as MSD outside the United States and Canada) and Ferrer.

NicOx S.A. is headquartered in France and is listed on Euronext Paris (Compartment C: Small Caps).

Risks factors which are likely to have a material effect on NicOx's business are presented in the 4th chapter of the « Document de référence, rapport financier annuel et rapport de gestion 2010 » filed with the French Autorité des Marchés Financiers (AMF) on February 29, 2012 and available on NicOx's website ( and on the AMF's website (

NicOx's Ordinary Shareholder Meeting on June 6, 2012:

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: NICOX via Thomson Reuters ONE


NicOx S.A.
Les Taissounieres
Bat HB4 - 1681 Route des Dolines - BP313 - 06906
Sophia Antipolis Cedex - France

Tel : +33 (0)4 97 24 53 00
Fax : +33 (0)4 97 24 53 99

Read at

comments powered by Disqus
NicOx SA